[ad_1] On June 26, 2020, Pfizer brought suit in a direct challenge to the application of health care fraud prohibitions enforced by the Office of the Inspector General for the U.S. Department of Health and Human Services (“HHS-OIG”). The lawsuit was filed in the U.S. District Court for the Southern District of New York.[i] In